Organovo specializes in 3D bioprinting technology to create functional human tissues. Their bioprinted tissues are used primarily for drug discovery, disease modeling, and preclinical testing. Organovo's technology holds potential for future applications in regenerative medicine and therapeutic tissue replacement. The company's innovative approach aims to improve the drug development process, reduce the reliance on animal testing, and advance the field of tissue engineering.
